CSIMarket



Immucell Corp  (ICCC)
Other Ticker:  
 

Immucell's ROA per quarter

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


Return On Assets (Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Total Assets Change 5.15 % 17.86 % 10.2 % 10.61 % 7.55 %
Y / Y Net Income Change - - -60.74 % - -
Net Income (TTM) in Millions 0 1 -0 0 -0
Return On Assets (TTM) 0.6 % 2.45 % -0.18 % 0.09 % -1.06 %
Total Ranking # 2834 # 1993 # # 2655 #
Total Assets (TTM) in Millions 46 47 44 44 44
Seq. Total Assets Change -1.53 % 5.02 % 0.53 % 1.15 % 10.37 %
Seq. Net Income Change - - -49.83 % - -


Roa Comment
Immucell Corp yielded Return on Asset in II. Quarter below company average, at 0.6 %.

Return on assets decreased compare to previous quarter, due to detoriation of net income.

Within Healthcare sector 206 other companies have achieved higher return on assets. While Return on assets total ranking has deteriorated compare to previous quarter from 1993 to 2834.

What is ROA?
Return On Assets Company Ranking
Within: No.
Industry # 6
Sector # 207
Overall # 2820

Return On Assets Statistics
High Average Low
9.46 %
4.93 %
0.09 %
(Dec. 30, 2015)   (Sep 30 2021)


Financial Statements
Immucell's Assets $ 46 Millions ICCC's Balance sheet
Immucell's Income $ -1 Millions Quarterly ICCC's Income Statement
ICCC's Income by Division See ICCC's Income by Division



Annual Return On Assets (Dec 31 2021)
FY 2021
(Dec 31 2020)
FY 2020
(Dec 31 2019)
FY 2019
(Dec 31 2018)
FY 2018
(Dec 31 2017)
FY 2017
Y / Y Total Assets Change 10.2 % 4.28 % 18.21 % -4.57 % 38.88 %
Total Assets in Millions 44 40 39 33 34
Y / Y Net Income Change - - - - -
Net Income in Millions -0 -1 -1 -2 -0
Return On Assets -0.18 % -2.53 % -3.35 % -7.09 % -0.49 %




More Return On Equity Ratios
In Vitro & In Vivo Diagnostic Substances Industry Return On Asstes Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ICCC's Roa Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and overall Market
Highest Ranking Return On Asstes
Lowest Ranking Return On Asstes
Roa for ICCC's Competitors
Roa for Immucell's Suppliers
Return On Asstes for ICCC's Customers

You may also want to know
ICCC's Roi ICCC's Inventory Turnover Ratio ICCC's Growth Rates ICCC's Dividend Comparisons
ICCC's Profitability Ratios ICCC's Asset Turnover Ratio ICCC's Dividend Growth
ICCC's Roe ICCC's Valuation Ratios ICCC's Financial Strength Ratios ICCC's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2022, within Healthcare Sector ROA
Viatris Inc.  1.41 %
Perrigo Company Plc  1.33 %
Exagen Inc.  1.23 %
Champions Oncology Inc.  1.21 %
Zimmer Biomet Holdings Inc.  1.02 %
Biomarin Pharmaceutical Inc  0.89 %
Sunlink Health Systems Inc  0.82 %
Community Health Systems Inc.  0.64 %
Immucell Corp  0.60 %
Lifeloc Technologies Inc.  0.42 %
Convey Health Solutions Holdings Inc.  0.24 %
Syndax Pharmaceuticals Inc.  0.22 %
Bausch Health Companies Inc.  0.20 %



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MBUU's Profile

Stock Price

MBUU's Financials

Business Description

Fundamentals

Charts & Quotes

MBUU's News

Suppliers

MBUU's Competitors

Customers & Markets

Economic Indicators

MBUU's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071